Market report
Dermatological drug tenders in Czechia — market report, March 2025
Dermatological drug tenders in Czechia in March 2025: 8,827 tenders published (-5% month on month, +39% year on year), estimated at €167,261 in total, and 8,846 contracts awarded (-5% month on month, +40% year on year), worth €26,562,599 (awarded value). Buyers with the most tenders: Fakultní nemocnice Bulovka (2,729), Krajská nemocnice T. Bati, a. s. (2,453) and Krajská zdravotní, a.s. (814); most contracts won: ViaPharma s.r.o. (427), ROCHE s.r.o. (244) and Gilead Sciences s.r.o. (139). On average 1.4 bids per contract; 75% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 8,827
- Contracts awarded
- 8,846
- Contract value awarded
- €26,562,599
- Bids per contract
- 1.4
The highlighted bar is March 2025. Hover a bar for its figure; the table below has every value.
| Figure | March 2025 | February 2025 | Change | March 2024 | Change |
|---|---|---|---|---|---|
| Tenders published | 8,827 | 9,302 | -5% | 6,332 | +39% |
| Estimated value | €167,261 | €122,469 | +37% | €2,183,076 | -92% |
| Buyers | 34 | 30 | +13% | 30 | +13% |
| Contracts awarded | 8,846 | 9,292 | -5% | 6,341 | +40% |
| Contract value (awarded) | €26,562,599 | — | — | €4,404,025 | +503% |
| Winners | 279 | 267 | +4% | 274 | +2% |
| Bids per contract | 1.4 | 1.8 | — | 1.3 | — |
| Single-bid contracts | 75% | 40% | — | 89% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ViaPharma s.r.o. | 427 |
| 2 | ROCHE s.r.o. | 244 |
| 3 | Gilead Sciences s.r.o. | 139 |
| 4 | Janssen-Cilag s.r.o. | 135 |
| 5 | Takeda Pharmaceuticals Czech Republic s.r.o. | 122 |
| 6 | Merck Sharp & Dohme s.r.o. | 120 |
| 7 | Amgen s.r.o. | 119 |
| 8 | Avenier a.s. | 103 |
| 9 | BAYER s.r.o. | 91 |
| 10 | AbbVie s.r.o. | 86 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Dermatological and musculoskeletal drugs
Questions and answers
- How many dermatological drug tenders were published in Czechia in March 2025?
- 8,827 (by 34 buyers); for comparison, February 2025: 9,302, March 2024: 6,332.
- Who won the most dermatological drug tenders in Czechia in March 2025?
- By number of contracts: ViaPharma s.r.o. (427), ROCHE s.r.o. (244), Gilead Sciences s.r.o. (139), Janssen-Cilag s.r.o. (135) and Takeda Pharmaceuticals Czech Republic s.r.o. (122); 279 companies won contracts in all.
- Which buyers published the most dermatological drug tenders in March 2025?
- Fakultní nemocnice Bulovka (2,729), Krajská nemocnice T. Bati, a. s. (2,453), Krajská zdravotní, a.s. (814), Fakultní nemocnice Brno (346) and Nemocnice České Budějovice, a.s. (306).
- How competitive were dermatological drug tenders in Czechia in March 2025?
- On average 1.4 bids per contract (20 contracts with a known number of bids); 75% of contracts had a single bid.
- What were the contracts worth in March 2025?
- €26,562,599 (awarded value, 8,846 contracts); median about €160,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.